The Ramsay (ASX:RHC) share price lifted 8% last time the company reported

Let's take a look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is enjoying a decent day of trading this Wednesday. The ASX 200 is currently up 0.16% to 7,515 points at the time of writing. However, in what might be some trepidation about it's earnings report tomorrow, the Ramsay Health Care Limited (ASX: RHC) share price is not enjoying the same treatment. Ramsay shares are currently trading at the rather unfortunate share price of  $66.66, down 0.48% for the day.

So as I just mentioned, Ramsay is scheduled to report its full-year earnings for FY2021 tomorrow morning. But while we wait with bated breath for these numbers, let's check out what the Ramsay Health Care share price did last time the company had an appointment with its investors.

So Ramsay reported its half-year earnings back in February of this year, 25 February to be precise.

Here's a summary of what the company reported at the time:

  • Revenues of $5.9 billion, a 6.6% fall over the previous corresponding period (pcp).
  • Statutory net profit of $226 million, a 12.5% drop over the pcp.
  • Diluted earnings per share (EPS) came in at 96.9 cents, a decline of 21.1% over the pcp
  • Earnings before interest and tax (EBIT) of $583.8 million, a 4.2% slump.
  • An interim dividend of 48.5 cents per share, fully franked, 21.1% lower than Ramsay's previous interim payout.
share price up

Image source: Getty Images

How did the Ramsay Health Care share price respond?

Despite these numbers showing a significant hit from the coronavirus outbreak, investors responded enthusiastically to these earnings back in February. As we covered at the time, investors sent Ramsay shares up around 8% in the first few hours of trading following this release. As it stands today, Ramsay shares are around 5.5% higher than the day before this report became public 6 months ago.

At the current Ramsay share price, the company has a market capitalisation of $15.32 billion, a price-to-earnings (P/E) ratio of 62.96 and a dividend yield of 0.72%.

This company is up 6.88% year to date in 2021 so far, but is only up 1.07% over the past 12 months. Disappointingly for its investors, the Ramsay share price is also down close to 12% over the past 5 years.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Female scientist working in a laboratory.
Healthcare Shares

Down almost 20% this year, how high could Mesoblast shares go?

The forward pipeline is looking promising.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?

These three stocks might be too cheap to ignore.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

How much would $10,000 become if CSL shares returned to their record high?

After a sharp decline, CSL is in a new phase. The question is what happens next.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Healthcare Shares

Why this ASX biotech stock just rocketed 89% today

Immutep shares rocket after a fresh FDA win

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX biotech stock just jumped again as its lead drug trial moves ahead

The latest trial milestone sends this ASX biotech stock higher today.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why are Telix shares sinking 7.5% today?

Let's see what this healthcare stock has announced today.

Read more »

A smiling businessman sits at a desk with bags of mony, indicating a share price rise after funding has been approved
Healthcare Shares

Telix Pharmaceuticals upsizes convertible bonds to US$600 million

Telix Pharmaceuticals has upsized its convertible bond issue to US$600 million, enhancing financial flexibility and repurchasing existing bonds.

Read more »